Full-Time

Director – WMS IT Product Lead

Posted on 11/1/2025

Deadline 11/11/25
Cencora

Cencora

10,001+ employees

Global pharmaceutical distribution and services provider

No salary listed

Remote in USA + 1 more

More locations: Conshohocken, PA, USA

In Person

Category
Product (2)
,
Requirements
  • Bachelor’s degree in Computer Information Systems or another related field, or equivalent work experience
  • Preferably 5 years in Information Technology in progressive levels of responsibility and leadership
  • High level understanding of several components of IT such as: Product Management, Technical Architecture, Business Analysis, Testing or Operations and Support.
  • Some budgetary responsibility preferred
  • Excellent written and verbal skills, including the ability to respond well under pressure
  • Strong leadership skills
  • Self-motivated and self-directed
  • Demonstrated ability to partner and collaborate across organizations to optimize outcomes
  • Demonstrates working knowledge of product management methodology
  • Understanding of basic SAFe Agile principles and methodology
  • Ability to prioritize work load and consistently meet commitments
  • Ability to work across multiple groups within IT to ensure end to end performance
  • Excellent interpersonal skills, must be comfortable working continually on a team with daily accountability for keeping commitments
  • Excellent written and oral communication, listening and presentation skills
  • In-depth knowledge of business operations
  • Good organizational skills
  • Ability to use good judgment in conveying status and problem escalation
  • Provides coaching and mentoring to team members
  • Knowledge of the cost basis for the service
Responsibilities
  • Plans for future changes to the product(s) to meet customer and business priorities needs
  • Works collaboratively with others: product owners, customer relationship managers and capacity planners to forecast demand
  • Partners with IT and business leaders to define opportunities to identify and prioritize items based on business needs and timetables
  • Maintains liaison relationship with business partners and IT partners to provide effective technical solutions
  • Drives continuous improvement in all areas impacting product(s)
  • Develops business-focused concepts, including risk, cost-benefit, strategic initiatives, task/defect fix prioritization
  • Aligns with IT strategy and architecture teams to understand the long-term product strategy roadmap
  • Fosters an environment of Design Thinking
  • Develops and maintains product roadmaps; plans for product end of life or retirement
  • Works with leadership and product owners to ensure that products are reflected in business plans
  • Interfaces with customers regarding product offerings, costs, value propositions, and on boarding processes
  • In conjunction with product owners develops customer communications strategy that facilitates and promotes awareness of significant events for the product(s)
  • Benchmark and manage the IT metrics established for the product team
  • Plans for future changes to the service to meet customer needs
  • Works with the business product owner to prioritize continuous improvement, pay down of technical debt, and manage defect resolution
  • Develops business-focused concepts including: risk management, cost-benefit, strategic initiatives, innovative solutions, and success measurements
  • Oversees the development of metrics that are aligned to and support the established business Key Performance Indicators (KPIs) for product
  • Oversees the development of and negotiates service-level agreements (SLAs) and Operational Level Agreements (OLAs) in support of their products
  • Assesses and evaluates risk as part of the life cycle analysis of the product; communicates risk to appropriate IT and business leadership providing clarity into the situation and recommends and directs risk mitigation options/plans
  • Defines and directs interaction with governance, audit, and quality teams
  • Removes technical and functional roadblocks of the product team, including coordination with other product teams, Centers of Competence and Enterprise Services
  • Working with financial analysts, analyzes the costs associated with delivering the product and identifying opportunities for improvement
  • May perform profit and loss analysis
  • Negotiates with other product groups, enterprise services, and centers of competence resources about the allocation of costs from infrastructure components or services that are shared among multiple products
  • Working with financial analysts, defines cost allocation, cost recovery and pricing plan within the overall context of the IT chargeback or pricing model
  • Ensures cost effectiveness of products
  • Identifies and/or approves needs for procurement of new assets to better deliver product capability
  • Identifies assets that are or will become obsolete and need of retiring
  • Documents improvement plans based on current asset deployment and need to replace/retire older/non-performing assets
  • Defines attributes such as performance, availability, security, etc.
  • Drives in internal product continuous improvement review meetings
  • Ensures that performance meets the requirements of KPIs, SLAs and OLAs
  • Develops and maintains performance dashboards, and scorecards in order to quantify and measure outcomes and to identify persistent problems
  • Regularly reviews the product to ensure the value realization is in line with the business and IT strategy
  • First point of contact in communications regarding high severity issues of the product the product team. Coordinates recovery and resolution to these high severity issues, and ensure a root cause analysis is provided to the business for the issue
  • In coordination with the VMO, manages and reviews vendor contracts for alignment with desired results
  • Provides input to the VMO with regards to decision-making and contract development processes
  • Regularly reviews service provider performance to identify and confirm performance problems; notifies Vendor and VMO management of issues and escalates to business and IT leaders with regards to vendor performance issues and improvement plans
  • Contractor Management: Oversight of contractor work and performance, including coordinating with Centers of Competence in identifying, onboarding and evaluating vendor performance
  • Responsible for the human resource management of the cross-functional product team members
  • In collaboration with the appropriate Centers of Competence, manage and evaluate goals, skills and training for associates on the product team
  • Participate in Agile SAFe methodology, especially in coordinating with other IT Product Leads in the same Product Train to reduce risks and ensure coordination of inter-dependencies.
  • Coaches and mentors product team associates, modeling the ideal behavior in communications, conflict resolution and sense of urgency.
  • Directly contributes to the team’s success by helping to execute when necessary including but not limited to user story creation, technical architecture and coaching, code reviews or acceptance criteria creation.
  • Other duties as assigned.
  • Proven experience in managing and integrating WMS solutions like Manhattan Associates solutions, including MAWM, WMi, WMOS, and Labor Management, across on-premise and SaaS environments
  • Deep understanding of top tier WMS vendor solutions architecture, configurations, and implementation best practices
  • Expertise in coordinating cross-functional teams to ensure seamless integration and performance optimization of Manhattan Associates solutions
  • Strong knowledge of cloud-native and hybrid deployment models, with a focus on scalability, security, and compliance
  • Ability to troubleshoot and resolve complex issues in distributed systems involving Manhattan Associates solutions
  • Familiarity with warehouse operations and labor management processes to align technical solutions with business needs
  • Pharmaceutical Distribution/ Life Sciences vertical experience is helpful including lot/expiration date tracking and serial number capture
  • Proficiency in leveraging analytics and reporting tools to monitor and optimize the performance of Manhattan Associates products
  • Bachelor’s degree in Computer Information Systems or another related field, or equivalent work experience
  • Preferably 5 years in Information Technology in progressive levels of responsibility and leadership
  • High level understanding of several components of IT such as: Product Management, Technical Architecture, Business Analysis, Testing or Operations and Support.
  • Some budgetary responsibility preferred
  • Excellent written and verbal skills, including the ability to respond well under pressure

Cencora provides global pharmaceutical distribution and a range of services, including specialty pharmacy, consulting, supply-chain management, patient support programs, and data analytics for healthcare providers, manufacturers, and veterinary practices. It works by combining physical drug distribution with value-added services such as inventory management, regulatory compliance guidance, patient support, and data-driven insights to optimize supply chains and outcomes. The company differentiates itself with an integrated, end-to-end offering that spans distribution, clinical services, analytics, and advisory support to help clients run more efficient operations and lower costs. Its goal is to improve healthcare outcomes by delivering comprehensive pharmaceutical solutions that enable better care and lower overall expenses.

Company Size

10,001+

Company Stage

IPO

Headquarters

Pennsylvania

Founded

1907

Simplify Jobs

Simplify's Take

What believers are saying

  • OneOncology $5B acquisition completed December 2025 boosts specialty oncology leadership.
  • EyeSouth retina business $1.1B deal expands Retina Consultants, accretive to EPS post-closure.
  • FY2026 EPS guidance raised to $17.65–$17.90 despite revenue headwinds from biosimilars.

What critics are saying

  • Frank R. Cruz investigation triggers shareholder lawsuits after May 6, 2026 Q2 revenue miss.
  • McKesson and Cardinal Health seize specialty drug share via aggressive GLP-1 pricing.
  • Inflation Reduction Act price cuts compress margins beyond $2B Q2 2026 headwind.

What makes Cencora unique

  • Cencora rebranded from AmerisourceBergen in August 2023, trading as COR on NYSE.
  • Cencora operates 1,400 locations across 50+ countries for global pharmaceutical distribution.
  • Cencora uniquely serves human and animal health with specialty pharmacy and MSO platforms.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Parental Leave

Adoption Assistance

Infertility Coverage

Family Planning Benefits

Behavioral Health Solutions

Professional Development Budget

Training Programs

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Mar 23rd, 2026
Cencora buys EyeSouth Partners' retina business for $1.1B to expand Retina Consultants of America

Cencora has signed a definitive agreement to acquire EyeSouth Partners' retina business for $1.1 billion. The affiliated retina physicians will join Cencora's Retina Consultants of America, a leading management services organisation. The pharmaceutical solutions company expects the acquisition to be slightly accretive to its adjusted diluted earnings per share in the first twelve months following closure, net of financing costs. The transaction requires regulatory approvals and customary closing conditions. Cencora's reaffirmed fiscal 2026 financial guidance does not currently include the transaction closing within that fiscal year. BofA Securities served as lead financial advisor to Cencora, whilst Jefferies advised EyeSouth Partners, a portfolio company of Olympus Partners.

The Associated Press
Mar 17th, 2026
Cencora CFO James Cleary to retire after eight years, search underway for successor

Cencora has announced that Chief Financial Officer James F. Cleary will retire effective 30 June 2026. The pharmaceutical solutions company has engaged an executive search firm to identify potential successors from internal and external candidates. Cleary, 62, has served as CFO since November 2018 and joined Cencora in February 2015 following its acquisition of MWI Veterinary Supply, where he had been chief executive officer for over a decade. He will serve in an advisory capacity through the end of 2026 to ensure a smooth transition. Cencora reaffirmed its previously issued adjusted diluted earnings per share guidance range of $17.45 to $17.75 for fiscal year 2026. The company, ranked number 10 on the Fortune 500, generates more than $300 billion in annual revenue.

TradingView
Feb 11th, 2026
Cencora prices $3B senior notes offering across multiple maturities

Cencora has priced a $3 billion senior notes offering across various maturities, the company announced on 10 February 2026. No further details about the specific maturities, interest rates or intended use of proceeds were disclosed in the announcement.

Yahoo Finance
Feb 4th, 2026
Cencora raises fiscal 2026 guidance after completing OneOncology acquisition

Cencora reported 12% adjusted operating income growth and 9% adjusted diluted EPS growth in its fiscal 2026 first quarter, driven by its US healthcare solutions business. The company raised its full-year guidance to reflect year-over-year adjusted operating income growth of 11.5% to 13.5%. CEO Robert Mauch announced the completion of Cencora's acquisition of the majority remaining equity interest in OneOncology. The deal strengthens Cencora's specialty pharmaceutical leadership and MSO (management services organisation) platform. Cencora's strategy focuses on three priorities: strengthening leadership in specialty pharmaceuticals, partnering with market leaders, and enhancing patient access to pharmaceuticals. The company is leveraging technology and advanced analytics to improve customer experience and operational excellence whilst expanding its pharmaceutical-centric MSO footprint.

Yahoo Finance
Feb 4th, 2026
Cencora beats profit estimates on specialty drug demand, completes $5B OneOncology acquisition

Cencora beat Wall Street's first-quarter profit estimates on Wednesday, driven by sustained demand for specialty medicines and GLP-1 therapies. The drug distributor reported adjusted earnings of $4.08 per share, exceeding analysts' expectations of $4.04. The company completed its $5 billion acquisition of OneOncology from TPG in December, strengthening its presence in cancer care. It raised its fiscal 2026 adjusted operating income growth forecast to 11.5% to 13.5%, up from 8% to 10% previously. However, quarterly revenue of $85.93 billion fell short of expectations of $86.03 billion, sending shares down 5% in pre-market trading. Sales at its largest unit, US healthcare solutions, rose 5% year-over-year to $76.2 billion, boosted by prescription volumes of weight-loss drugs and specialty medicines.

INACTIVE